HH
KRYS icon

Hilltop Holdings’s Krystal Biotech KRYS Stock Holding History

Hilltop Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,468
Closed -$202K – 947
2025
Q2 		$202K Buy
1,468
+272
+23% +$40K 0.01% 826
2025
Q1 		$216K Buy
+1,196
New +$201K 0.01% 783
2024
Q4 		– Sell
-1,146
Closed -$209K – 869
2024
Q3 		$209K Buy
+1,146
New +$221K 0.01% 762

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hilltop Holdings's KRYS Position: Q3 2025 in Review

Hilltop Holdings sold out of Krystal Biotech (KRYS) in Q3 2025, closing a stake of 1,468 shares — an estimated $202K sold.

Hilltop Holdings first reported a position in KRYS in Q3 2024 and held it in 3 quarters. The position peaked at $216K in Q1 2025. 284 funds tracked by Wall St. Rank hold KRYS as of Q3 2025.

  • Hilltop Holdings reported no remaining Krystal Biotech position as of Q3 2025 after selling out during the quarter.
  • Hilltop Holdings sold 1,468 Krystal Biotech shares in Q3 2025, an estimated $202K.
  • Hilltop Holdings first reported a position in Krystal Biotech in Q3 2024 and held it in 3 quarters.
  • Hilltop Holdings's Krystal Biotech position peaked at $216K in Q1 2025.
  • 284 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2025.

Based on Hilltop Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.